APA (7th ed.) Citation

IHF, d. C., CAM, d. P., PL, d. M. D., LP, S., JS, M., RMM, D. S., & AMM, R. (2023). Comparison of three risk assessment models for thromboembolism in multiple myeloma patients receiving immunomodulators: A Brazilian historical cohort. Journal of thrombosis and thrombolysis, 56(1), 147. https://doi.org/10.1007/s11239-023-02817-7

Chicago Style (17th ed.) Citation

IHF, da Costa, de Pádua CAM, de Miranda Drummond PL, Silveira LP, Malta JS, Dos Santos RMM, and Reis AMM. "Comparison of Three Risk Assessment Models for Thromboembolism in Multiple Myeloma Patients Receiving Immunomodulators: A Brazilian Historical Cohort." Journal of Thrombosis and Thrombolysis 56, no. 1 (2023): 147. https://doi.org/10.1007/s11239-023-02817-7.

MLA (9th ed.) Citation

IHF, da Costa, et al. "Comparison of Three Risk Assessment Models for Thromboembolism in Multiple Myeloma Patients Receiving Immunomodulators: A Brazilian Historical Cohort." Journal of Thrombosis and Thrombolysis, vol. 56, no. 1, 2023, p. 147, https://doi.org/10.1007/s11239-023-02817-7.